Can fatigue predict walking capacity of patients with Parkinson’s disease?
| dc.creator | Davi Vilela Carvalho | |
| dc.creator | Renata Maria Silva Santos | |
| dc.creator | Helen Cardoso de Magalhães | |
| dc.creator | Mariana Soares de Souza | |
| dc.creator | Paulo Pereira Christo | |
| dc.creator | Camila Megale de Almeida Leite | |
| dc.creator | Paula Luciana Scalzo | |
| dc.date.accessioned | 2023-04-14T21:39:46Z | |
| dc.date.accessioned | 2025-09-09T01:02:08Z | |
| dc.date.available | 2023-04-14T21:39:46Z | |
| dc.date.issued | 2020-02 | |
| dc.description.abstract | Embora a fadiga seja um sintoma importante na doença de Parkinson (DP), poucos estudos investigaram a associação entre fadiga, mobilidade e capacidade de marcha nesses pacientes. Objetivo: Investigar se a fadiga é um fator independente associado à mobilidade e à capacidade de marcha em pacientes com DP. Métodos: Quarenta e oito pacientes com DP (22 com fadiga) foram avaliados com testes de mobilidade e capacidade de marcha: Timed Up and Go (TUG), Teste de Caminhada de 10 metros (T10m) na velocidade usual e máxima, Teste de Caminhada de Seis Minutos (TC6m). A fadiga foi medida pela Escala de Fadiga no Parkinson (PFS-16). A análise de regressão linear foi utilizada para investigar se a fadiga é um fator independente que contribui para a variação na mobilidade e capacidade de marcha. Resultados: Houve correlação positiva entre PFS-16 e TUG (rs=0,385; p=0,007). Houve correlação negativa entre PFS-16 e T10m na velocidade usual (r=-0,385; p=0,007) e máxima (r=-0,396; p=0,005) e TC6m (r=-0,472; p=0,001). Análise de regressão linear revelou que a fadiga não explicava a variância do TUG e T10m. A PFS-16, a idade e a seção III da UPDRS explicaram 49,6% (R2 ajustado, p<0,001) da variância no TC6m e a fadiga foi o preditor mais significativo (F=-32,1; p=0,022). Conclusões: A fadiga é um fator independente que contribui para a distância percorrida durante o TC6m em pacientes com DP. Nossos resultados destacam a importância do reconhecimento e manejo desse sintoma. | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1590/0004-282X20190136 | |
| dc.identifier.issn | 1678-4227 | |
| dc.identifier.uri | https://hdl.handle.net/1843/52030 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Arquivos de Neuro-Psiquiatria | |
| dc.rights | Acesso Aberto | |
| dc.subject | Doença de Parkinson | |
| dc.subject | Fadiga | |
| dc.subject | Limitação da mobilidade | |
| dc.subject | Velocidade de caminhada | |
| dc.subject | Caminhada | |
| dc.subject.other | Parkinson’s disease | |
| dc.subject.other | Fatigue | |
| dc.subject.other | Mobility | |
| dc.subject.other | Gait speed | |
| dc.subject.other | Walking capacity | |
| dc.title | Can fatigue predict walking capacity of patients with Parkinson’s disease? | |
| dc.title.alternative | A fadiga pode predizer a mobilidade e a capacidade de marcha em pacientes com doença de Parkinson? | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 75 | |
| local.citation.issue | 2 | |
| local.citation.spage | 70 | |
| local.citation.volume | 78 | |
| local.description.resumo | Although fatigue is an expressive symptom of Parkinson’s disease (PD), few studies have investigated the association between fatigue, mobility and walking capacity of these patients. Objective: To investigate whether fatigue is an independent factor associated with mobility and the walking capacity in patients with PD. Methods: Forty-eight patients with PD (22 with fatigue) were tested for mobility and their walking capacity: Timed Up and Go (TUG), 10-Meter Walk Test (10MWT) at usual and fastest speed, and 6-Minute Walk Test (6MWT). Fatigue was measured with Parkinson’s Fatigue Scale (PFS-16). Linear regression analysis was used to investigate if fatigue is an independent factor contributing to variance in mobility and walking capacity. Results: There was a positive correlation between PFS-16 and TUG (rs=0.385; p=0.007). There was a negative correlation between PFS-16 and 10MWT at comfortable (r=-0.385; p=0.007) and fast speeds (r=-0.396; p=0.005), and 6MWT (r=-0.472; p=0.001). Linear regression analysis revealed that fatigue did not explain the variance of TUG and 10MWT. PFS-16, age and section III of UPDRS explained 49.6% (adjusted R2; p<0.001) variance in the 6MWT, and fatigue was the most significant predictor (F=-32.1; p=0.022). Conclusions: Fatigue is an independent factor contributing to the distance covered during 6MWT in patients with PD. Our results highlight the importance of recognition and management of this symptom. | |
| local.identifier.orcid | https://orcid.org/0000-0002-7994-8325 | |
| local.identifier.orcid | https://orcid.org/0000-0001-5737-7712 | |
| local.identifier.orcid | https://orcid.org/0000-0003-0582-305X | |
| local.identifier.orcid | https://orcid.org/0000-0002-5301-003X | |
| local.identifier.orcid | https://orcid.org/0000-0003-1383-8550 | |
| local.identifier.orcid | https://orcid.org/0000-0003-2694-8521 | |
| local.identifier.orcid | https://orcid.org/0000-0003-1383-8550 | |
| local.publisher.country | Brasil | |
| local.publisher.department | HCL - HOSPITAL DAS CLINICAS | |
| local.publisher.department | ICB - DEPARTAMENTO DE MORFOLOGIA | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.scielo.br/j/anp/a/P6gxw5p9bQnHhgX46VmCjtB/?lang=en# |